Click here to get in touch with the Profounda Team.
Toll Free: (800) 407-6810
October 2, 2018
October 22, 2017
December 31, 2016
Sales of Impavido, Rhinase Soothing Nasal Gel and Rhinase Lubricating Mist exceeded $2.5 M for 2016 making it a great start for Profounda as it looks to introduce new products to the market in 2017.
Orphan indication received by Profounda is for the treatment of Acanthamoeba Keratitis, also commonly known as AK usually associated with contact lens wear.
December 16, 2016
Orphan indication received by Profounda is for the treatment of PAM, also commonly known as the Brain Eating Amoeba
Dec 15, 2016 Profounda, Inc. ("Profounda") announced today that it has received, the US Food and Drug Administration’s (FDA) Orphan Drug...